| 000 | 01662 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250513111528.0 | ||
| 264 | 0 | _c19970401 | |
| 008 | 199704s 0 0 eng d | ||
| 022 | _a0921-299X | ||
| 024 | 7 |
_a10.1007/BF02620733 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aUsui, N | |
| 245 | 0 | 0 |
_aAntitumor effects of human recombinant interleukin-1 alpha and etoposide against human tumor cells: mechanism for synergism in vitro and activity in vivo. _h[electronic resource] |
| 260 |
_bBiotherapy (Dordrecht, Netherlands) _c1996 |
||
| 300 |
_a199-208 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 | _aDrug Synergism |
| 650 | 0 | 4 |
_aEtoposide _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInterleukin 1 Receptor Antagonist Protein |
| 650 | 0 | 4 |
_aInterleukin-1 _xadministration & dosage |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred BALB C |
| 650 | 0 | 4 |
_aNeoplasms, Experimental _xdrug therapy |
| 650 | 0 | 4 |
_aRecombinant Proteins _xadministration & dosage |
| 650 | 0 | 4 |
_aSialoglycoproteins _xpharmacology |
| 650 | 0 | 4 |
_aSuperoxide Dismutase _xmetabolism |
| 650 | 0 | 4 |
_aSuperoxides _xmetabolism |
| 650 | 0 | 4 | _aTumor Cells, Cultured |
| 700 | 1 | _aMatsushima, K | |
| 700 | 1 | _aPilaro, A M | |
| 700 | 1 | _aLongo, D L | |
| 700 | 1 | _aWiltrout, R H | |
| 773 | 0 |
_tBiotherapy (Dordrecht, Netherlands) _gvol. 9 _gno. 4 _gp. 199-208 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/BF02620733 _zAvailable from publisher's website |
| 999 |
_c9003452 _d9003452 |
||